Friday, December 31, 2010
Southern Ispat ( 531645 )
This is a case of sheer undervaluation of stock. Again this is no great analysis. I just managed to chance upon the stock. If one of you would have looked at the financials I think you too could have recommended this stock as an investment opportunity.
This was just one of the companies till the end of FY09. However, it is after FY09 when the management started taking a more aggressive strategy. And thus last year that is FY10 has been stellar.
Lets just give you pointers to what I saw.
a) Revenues have grown from Rs 39 odd crores in FY09 to 272 odd crores in FY10 (about 7 times)
b) Profit before interest and tax has grown from Rs 1.56 crores in FY09 to Rs 9.78 crores in FY10 ( about 6 times)
c) PAT has grown from Rs 0.73 crores in FY09 to Rs 7.33 crores in FY10 (10 times increase)
d) However during the same time the interest has gone up from Rs 52 lacs to Rs 62 lacs. The interest numbers not going up too much suggests that the growth is not burdened by debt.
If you look at the 1st quarter numbers they seem to vindicate that the company is clearly on a growth path.
(June 2010 results). Don't think these would need any further analyses.
So what next is in store for us. The following news flows could give some pointers to the future prospects of the company.
a) Meger of privately held Kerala Sponge with itself
b) Own power generation through waste heat recovery in the steel plant as well as coal based plants.
c) Purchase of company in Gujarat. (Management interview)
this mean -->
a) The company is integrating both backward and forward and this am sure will be reflected in the financial performance in future.
b) It is also alive to the opportunity that generation of power presents in current times.
c) The forward integration is infact even more interesting when the product portfolio of Newtech is looked at.
Did someone mention getting into auto parts manufacturing? Well if the entire company is being acquired then that is what is going to happen.
The company has just recently concluded a GDR issue of about 3.23 crore shares.
Now the interesting bit. On 27th of May 2010 1 crore warrants were issued to non promoters at Rs 32 per share (Rs 10 face value + Rs 22 premium).
So Investing This Share .........
Note :: Before Investing Please Read the my blog Disclaimer Label.
Sunday, October 24, 2010
HIDDEN PRECIOUS GEM --- ARVIND REMEDIES LTD (BSE CODE : 531823)
HIDDEN PRECIOUS GEM --- ARVIND REMEDIES LTD (BSE CODE : 531823)
STOCK : ARVIND REMEDIES LTD. Trading in BSE Code : 531823.
Promoters Buying Heavily….. Increasing Stake
Target : 5.5/- to 7.5/- in Short term and Medium terms
Equity : 26 Cr
Promoters Holding : 25% (Buying Heavily by promoters to increase stake); Financial Institutions and Banks and Body Corporate : 13%.
Face Value : 1/-
EPS : 1/- above (As per 20010-11 June Quarter) Estimate d EPS for Full Year above 1.5/- ( Expansion Income will Add)
Book Value: 2.9/-
Dividend History : 2010 --- 5%; 2009 --- 5%; 2008 --- 5%; 2007 --- 5%; 2006 --- 5%
Arvind Remedies Ltd doing Pharma Business; Recently all Pharma Stocks up 50% to 100% by future Growth. Arvind Remedies also in Pharma Business and Expanding Business more and more and Having Good Land Bank and Valuable Assets. So Soon Stock will go 5/- to 7/- minimum.
Arvind Remedies Ltd Expanding plans is very Aggressive. Unit 2 Income and netProfit will come this Quarter onwards. And The project is being implemented to manufacture principally, the injectables (vials and ampoules) softgel, tablets, capsules and ointments all with aim of USFDA, TGA, MHRA, EMEA and cGMP certification. This Unit will have the approval of –
1. USFDA - USA
2. MHRA - UK
3. TGA - Australia
4. EMEA - Europe
5. cGMP - WHO
6. MCC - South Africa
7. ANVISA – Brazil
Arvind Remedies Ltd Stock Will go 5.5/- to 7.5/- range in Short term and Medium Term,
For 2010-11 June Quarter Posted Net Income of 82 Cr and Net Profit of 5.9 Cr with Equity 26 Cr. As per This EPS is 1/- Annualized But in coming Quarters Expanding Income will add So Expecting EPS for 2010-11 is 1.5/-. Stock Trading at 2.3/- PE just 2 Industry PE is 25. As per this Stock will zoom to 15/- +++ levels in 1 year time.
A Long Term Story….........ARL Manufacturing Unit -2 ( US FDA ) ready by March 2011
Arvind Remedies Limited to be a Global Player in the Pharmaceutical Industry by Manufacturing and Marketing Quality Medicinal Products both in Allopathy and Ayurveda.
Arvind Remedies Limited set out to manufacture and market world-class allopathic and ayurvedic pharmaceutical products within and outside India, thus beginning to realize the vision of bringing high quality healthcare to the common man. Since then, we have come a long way. Having grown notably in terms of production capacity, product categories, market share, advancements in R & D, market reach and global acceptance, we are today a significant force to reckon with in the Indian Pharmaceutical Industry.
Unit 2 is located in the area of 1,65,528 square feet (3.8 acres) of land allotted at plot No.G28 & G29, SIPCOT Industrial Park, Irungattukottai, Kanchipuram District, Tamil Nadu which is on the Chennai-Bangalore Highway, 34 km from Chennai. The site is accessible from existing Chennai Airport and Sriperumbudur Airport (Proposed). The estimated cost of project is to the tune of $ 55 Million (Rs.250 Crores) and it will provide employment opportunity to around 500 persons The project is being implemented to manufacture principally, the injectables (vials and ampoules) softgel, tablets, capsules and ointments all with aim of USFDA, TGA, MHRA, EMEA and cGMP certification.
Salient Features of this unit
Tablets 1.8 billion
Capsules 450 million
Liquids 15 million
Ointments 30 million
Injectables
Ampoules 15 million
Vials 30 million
Factory location advantages are
1. Proximity to Chennai renders easy availability of qualified and skilled manpower, raw materials, packaging materials, consumables and support services like transportation, repair and other facilities
2.Existing production facilities of the company at Kakkalur is just 25 km from the unit
3.Power infrastructure is well developed within the industrial park
4.Adequate supply of water by SIPCOT
5.Well developed sewage and effluent drainage exists in the industrial park
6.Good Environmental Structure given by SIPCOT for Manufacturing the Products
As per the schedule of implementation, the project will be ready for commissioning by March 2011
Arvind Research Centre (ARC) boasts of a sophisticated Research & Development Laboratory well-equipped with the latest Technologies and Machineries.
Arvind Remedies Limited well-qualified and committed R&D Team of over 15 Research Scientists, Doctors, Ayurvedic Specialists and Chemists are the primary driving force in our R&D efforts.
Arvind Remedies Limited focus areas are Development of Drug Delivery Systems, New Formulations, Process Development of Various Dosage Forms. The six major areas where R&D works on are:
1. Ayurvedic Formulation Development
2. Allopathic Formulation Development
3. Process Development and Validation
4. Novel drugs delivery development
5. Nutraceuticals
6. Analytical Development.
Today, the Indian Pharmaceutical industry is on the verge of undergoing a paradigm shift. While preparing to meet the challenges of product patent regime, it is reformulating its growth strategies to make its mark in the global arena. The foundations of this are based in solid research, which is the crux of any technological innovation.
Arvind Remedies Limited high-tech research center has been set up at Kakkalur, Tamil Nadu for the enhancement of research capabilities with focus on the core areas of Diabetology, Cardiology and Nephrology using age-old Herbal Medicines, Nutraceuticals and anti infective segments.
Key Focus Areas and Products
In the Diabetology segment, PANKARE a herbal combination is found as an efficient treatment for Diabetes developed by our R&D. PANKARE Tablets is a scientifically and clinically developed herbal formulation for treatment of Diabetes and offers restoration, regeneration and rejuvenation of pancreatic beta cells. It also possesses anti-oxidant, anti-hypertensive and hypocholesterolmic properties.
In the Cardiology segment, ARC 1056, a Herbal combination was developed to treat Coronary Artery Disease and cure Cardio Vascular Problems, ARC 1056 has entered Phase II clinical trials after successful completion of Phase I clinical studies with the increase in the incidents of Cardio Vascular problems, owing to stressful modern day lifestyle, this segment holds great potential for development.
In the Nephrology segment, ARC 2098, a herbal combination indicated for patients undergoing dialysis has entered Phase I of clinical trial.
In the Dermatology segment, Sorexil brings solace to the un-addressed problem of Bedsores in chronic bedridden patients. It is an indigenous combination of Aloe, Neem Oil, Castor Oil with PMFA Technology and offers relief from Bedsores, Diabetic Ulcers, Pressure Sores, Venous Ulcers, Burns, Cuts and Wounds. Besides healing wounds, Sorexil leaves lesser marks and no Keloids. Arvind Remedies Limited are perhaps the first Company to introduce a cure for Bed sores, through this Ayurvedic product in the form of trans dermal delivery.
Another herbal combination indicated for wound dressings, ARC 190, is in the Phase II clinical trials. This product is an extension of Sorexil. ARC 190 dressings with Sorexil gel is a revolution in this area. So far the Clinical trials have shown excellent results. Surgical wound dressing has a huge market potential of over Rs.300 Crores and the need is enormous. This product is a boon to Surgeons and to suffering patients.
Arvind Remedies Limited have two unique products of solufact'O' & solufact'C' which are proven for its efficiency in reducing weight promisingly in obese people and help in controlling blood chloesterols. Both are clinically proven in Phase II.
In Nutraceuticals, we are developing products for Pregnant Women, Diabetics, Geriatrics and Cardiac patients.
R & D pipeline has a number of Herbal products, in the development stage, and a new Herbal Product is expected to be launched every 9 to 12 months.
Arvind Remedies Limited having Lot Expansion Plans in Fututre. Its a Multibagger stock. Just buy and hold 1 year will get 5 times Return like SE Investments Ltd (This Stock I have Recommended at 175/- levels after that reached 1200/- levels including Bonus and Split).
Positive Points for this stock for Up moving:
1) Company is in Pharma Business; company Circle people and Operators are accumulating at current price. Because Company Stock Good Value at 2.3/- Good Profit making company and Good dividend paying company.
2) Equity is very small at 25 Cr promoters Holding 25%
3) Company recently going Expansion Plans Unit 2 and aim of USFDA, TGA, MHRA, EMEA and cGMP certification.
4) Good Profit Making Company for 20010-11 EPS 1/- Annualised and Expecting EPS for full year is above 1.5/-because Expansion income will add next Quarters.
5) Company having Good Land Bank and Good Assets.
6) Company having lot of Expansion Plans in Future .
7) FII's Eyes in this stock. If they will start buy Stock will zoom to 5/- to 15/- levels
8) Risk Free at Current Market Price, Its very Cheap price Trading at 2.3/- Compare to companies Reserves, Assets and Value and Equity and Profits and Future Plans.
9) This Stock is not Participated this Market Rally. So Operators and FII';s eye's in this stock.
Happy Invest … Good Fundamental CALL and will give good returns & BEFORE INVESTING PLEASE READ ALSO MY DISCLAIMER LABEL.
"HAPPY DIWALI TO ALL OF U "
Saturday, September 18, 2010
530555:BSE
Read discliamer label before invest.
SATYAM
Current market price: Rs 91.85
Target price: Rs 125.
Upside: 36.09%
Mahindra Satyam has done reasonably well after Mahindra group took over the management control of the company. There has been no announcement about any major client breaking up their association with the company in last one year. In fact, in last 18 months, Satyam has secured over 40 orders - both big and small. It has successfully delivered project for FIFA World Cup. With continued order flow, clientele retention, and efficient manpower in place; i believes the company is well in growth mode. The company is expected to declare results by the month end after a gap of around 2 years. i expects the results to be quite better than expected. In fact, it believes the revenue would be above Rs 80 billion for FY10. Margins might be a bit low but under the table management of Mahindra, it believes the company will improve the margins at the levels of its peers in due course of time. Currently, the stock trades at Rs 91.85. Even with a conservative revenue estimate, the stock trades at 1.38x on Market Cap to Sales compared to an average of 3.75x for top 10 companies (by market cap, except Financial Technologies). The above is based on a number of assumptions and a fall in share prices is not ruled out in the event the results are not in line with the assessment or there are negative surprises on the liabilities front. Therefore, it would be prudent for investors to wait for the announcement of results and other important details about the financial position of the company. However traders willing to take high risk can accumulate the stock around current market price for a target of Rs 125 - 145 - 185 as soon.
Read Disclimer label before investing & invest at your own risk.
Thursday, September 16, 2010
mkt. trading
Rules
Whenever Market is High It Will Fall
Whenever Market is Low, If there is no external Factor, It Will rise
Same Rules Applies To Stocks Scripts Also
Always follow Indian stock market.
When market falls, don’t panic, when market zooming don’t be overjoyed as you can earn and loose both ways around.
Do and Dont’s For Stock Market Investmentsck Market Investments
This is the question probably every equity investor would have asked himself a number of times
What you Must NOT Do in Stock Market
Don’t panic
Don’t make huge investments
Don’t chase performance
Don’t ignore expenses
Don’t panic
What You Must Do in Indian Stock Market
Don’t panic
Get Rid of the Junk
Diversify
Belive in your Investment
Stick To your Strategy
Read Disclaimer Label
Web Resource
Official website of National Stock Exchange, India’s largest stock exchange. Official website of Bombay Stock Exchange, India’s oldest stock exchange. Official website of National Commodities and Derivatives Exchange, India’s largest derivatives exchange for agricultural commodities.
MCX Stock Exchange, India’s largest exchange for currency derivatives. Multi Commodity Exchange of India Ltd. (MCX), India’s No. 1 commodity exchange National Multi commodity Exchange is the oldest commodity exchange in India.
Securities and Exchnge Board of India, Regulator of financial markets. Forward markets Commission, Regulator for the commodities futures markets. Central Depository Services Limited
National Depository Services Limited. www.FTKMC.com, an excellent resource for your education on financial markets. India’s leading financial newspaper
One of India's largest media companies, excellent resource for latest news and updates. A reliable resource for financial news and information.
An excellent resource for local and international financial news and updates An excellent resource for Global financial news An excellent resource to track international stock indices and financial updates.
One of the leading providers of financial news, data and information. A dedicated news channel for business, economy and finance NSE TAME ® (Technical Analysis Made Easy) is a technical analysis tool provided by NSE to its members. This tool shall provide users an exhilarating experience in carrying out technical analysis.
The BSE Plus includes a wide range of features about a company's Equity, Filing Info, Peer group and Charting. The company's daily stock price movement, weekly, yearly history and market depth are also available in a single page.
Saturday, September 11, 2010
WISHES
HAPPY "GANESH CHATURTHI" AND HAPPY "EID" AND OUR Samsari "FORGIVENESS DAY" PLEASE FORGIVE US FOR THE PAST DEEDS AND MISTAKES MADE BY ME. BE GRACIOUS ENOUGH TO FORGIVE US ON THIS UNIVERSAL DAY OF FORGIVENESS. " MICHAMI DUKADAM".
Tuesday, September 7, 2010
Computer Vs. Hindi Films
1) Pentium III & Pentium I - Bade miyan Chhote miyan.
2) Computer infected by Virus - Pyar to Hona hitha.
3) Hard disk and Floppy disk - Gharwaali Baharwaali.
4)F1 - Guide.
5) Esc - Nau Do Gyarah.
6) Ctrl+Alt+Del - AkhriRastaa.
7) CrtlC + CtrlV - Duplicate.
8) Undo - Aa ab lautchale.
9) Super User Password - Gupt.
10) BackUp - Jaagteraho.
11) UPS - Janta Hawaldar.
12) Server -Godfather.
13) Proxy Server - Padosan.
14) Security -Nakabandi.
15) Storage - Tehkhana.
16) Storage capacity -Badhti ka naam Dadhi.
17) Computer without RAM - KoraKagaz.
18) Computer whose OS is DOS - Buddha mil gaya.
19)System which frequently requires bootable disk - Sharabi.
20) DumbTerminal - Anari.
21) Mouse - Jaanwar.
22) Hard Disk partition- Batwara.
23) Hardware & Software - Ek duje ke liye.
24)Temporary file - Khote Sikkey
Monday, August 30, 2010
Friday, August 27, 2010
good Buy “FAZE THREE LTD” (BSE Code: 530079) at CMP
FAZE THREE LTD Trading in BSE (BSE Code: 530079), Doing Furniture, Furnishing, Paints Business.
Face Value : 10/-
Equity : 12Cr
Book Value : 47/-
CMP : 17/- to 18/-
EPS for 2009-2010 is 3.75/- PE just 4. Avarage PE is 15 as per this Stock will zoom to 45/- soon.
Company having Huge Land Bank in
Mumbai ( Plot with Building),
Dadra & Haveli (9 Acres Land)
New Delhi (Plot with Building)
Gujarat ( 13 Acres Land)
Total Land value is Nearly 135 Cr Equity 12 Cr as per this per share it will come to 125/-. Stock trading at 17/- to 18/- So Good worth to Buy This stock at 17/- to 18/- levels , You will get 100% to 300% return in 1 year time.
GOOD STOCK.... AMBICA AGARBATHIES & AROMA INDUSTRIES Ltd (BSE Code : 532335) and NSE At 14/-; TARGET 27/- & 35/- and 57/-
ROCKET STOCK.... AMBICA AGARBATHIES & AROMA INDUSTRIES Ltd (BSE Code : 532335)
and NSEAt 14/-; TARGET 27/- & 35/- and 57/-
BUY AMBICA AGARBATHIES & AROMA INDUSTRIES Ltd. at 14/- Target 35/- and 57/-
BUY AMBICA AGARBATHIES & AROMA INDUSTRIES Ltd doing WindPower Generation, Hotel
Business, Infra Business and Agarbathies business; Stock Trading in BSE (Code :
532335) and NSE,Equity 16 Cr Promoters Holding 45.5% Corporate Bodies 20%
Public only 35% Target 35/- ;
AMBICA AGARBATHIES & AROMA INDUSTRIES Ltd Trading in BSE (Code : 532335) and
NSE; This stock is not participated for this market rally. Last 6 months trading
between 12/- to 17.5/-; So all bulls are eyeing in this stock to grabbing for
Good Value stock.
Public holding is only 35%. Net worth of company is around 100 crores,so
operators are accumulating public shares. Soon it will burst on restructuring
infra, hotel, wind power and aroma.
AMBICA AGARBATHIES & AROMA INDUSTRIES Ltd having good Book value at 17/- and
Good promoters Holding, And Good Dividend paying company.
Recently company allotted stocks at 18/- to M/s Trinethra Infra Ventures Ltd and
Mr. Puvvada Bhaskar Rao -for expanding future business plansfor Wind Power.
Good Valuable Buy AMBICA AGARBATHIES & AROMA INDUSTRIES Ltd; 10/- face Value
Trading at 14/- with Target of 35/-. Risk is very very less because company
stock was very Valuable because Book valueat 17/ and Good profit making Company
and Good Properties in Hyderabad , Eluru, Chennai, Rajam and Adoni.
AMBICA AGARBATHIES & AROMA INDUSTRIES Ltd declared results with 65 Cr Income abd
1.5 Cr Net profitand EPS 1.2 for 2008-09 and for 2009-2010 estimated Income 75
Cr and NetProfit 1.9 Cr with EPS of 1.7/- and declaring dividend also.
Just Buy and hold1 month to 6 months with good appreciation at 100% to 300%
return.
Lot of Accumulation is going on in NSE an BSE by Company circle people and
operators Because Company engaged in WindPower Generation, Infra, Hotel and
Agarbathies and stock has good valuable at 14/- and less Equity 16 cr. Dividend
Paying company.
Company having lot of Expansion Plans in future;Its Multi bagger stock in
Future.
Company having lot of reserves and net asset values; In Chennai 3 star
Hotelworth of 40 Cr and others lands and factories worth of total 150 Cr. But
Equity is just 16Cr means Per Share its worth around 95/-.
Company doing business and assets as follows:
AMBICA WIND POWER PROJECT: To rovide lowest possible cost solution to problem of
electric industry by deploying state of the art technologies in quality projects
with little customer risk. A Developer of Electricity generation Project with a
special skills, from site selection through construction.
Company Planning to expand in Wind Power Business.
AMBICA EMPIRE – Hospitality:Ambica empire a star hotel at Chennaiaffiliated to
BEST WESTERN INC, USA a chain with over 4000 hotels . A property worth of RS 400
million with amenities include 100 rooms, 2 multicusine restaurant, Bar, 3
Banquet hall with a strong corporate clients.
AMBICA REAL ESTATE and Infra: Ambica Real Estate has developed a farm land with
resort club house, health center with all facilities. Sucessfully marketed the
project in a record time of 50 days with 600 members.Promoted real estate
project in the prime locality of green city bangalore.with overall project cost
of RS 250 million .
Ambica Film Production & Distribution: Produced Successfull 3 Featured film with
major directors with a total project cost of RS 150 Million.Successfully
distributed 500 movies over a period of 10 years. Constructed multiplex Air
conditioned theatre in 40,000 SQ.FT Valued at RS 50 MILLION.
AMBICA NEW VETURES: Company has diversified its range of operation to
construction of shopping malls has successfully finished the project of
constructing vijayawada mall @76,000 sqft and vizag mall of 49,000 sqft
comprising abundant space to house of several branded show rooms and shopping
facilities along with a range of food courts and entertainment hubs for all.
Ambica agarbathies is profit making and a dividened paying company since from
the year of inception.
Factories established at eluru, hyderabad, rajam and adoni in Andhra pradesh
with total built up area of 300,000 sq ft.
Huge manpower engaged in production
Wide established dealer network Globally.
More than 500 active dealers operating at various places globally.
Having successful records of over 6 decades, Established as market leaderin
agarbathies and Aroma
industries in INDIA .
Share Holding:-
The Promoters holding 45.5%, Corporate bodies hold 19.5%, and Public only 35% .
6 Months Back I given Call for SE Investments at 175/- Reached 1000/- above
(Calculate with Bonus and Split share).
Now I am recommending AMBICA AGARBATHIES & AROMA INDUSTRIES Ltd at 14/- just
check after 6 months may be get 100% to 350% return, with Target of 35/- and
75/-. No risk at present rate at 14/- Good valuable Stock in Future as per
company plans in Wind Power Generation.
Positive Points for this stock for Up moving:
1) Company is in Wind Power Generation, Hotel Business, Infra and
Agarbathies. company Circle people and Operators are accumulating at current
price. Because Company Stock Good Value at 13.9/- Good Profit making companyand
Book Value at 17/- and Good dividend paying company.
2) Equity is very small at 16 Cr promoters Holding 45.5% and Corporate
Bodies 19.5% and Public 35%.
3) Company recently allotted shares at 18/- to M/s Trinethra Infra
Ventures Ltd and Mr. Puvvada Bhaskar Rao – for company future expansion plans in
Wind Power Generation.
4) Good Profit Making Company for 2008-09 EPS 1.7 and Estimated EPS for
2009-10 is 2.3/- and 2010-11 EPS will zoom for Expansion income and Profits will
come.
5) Company having Good Reserves and Good Assets in Hyderabad , Chennai,
Eluru Adonia and rajam. In Chennai Hotel Property worth of 40 Cr and Shoppring
Malls and other lands all over worth is nearly 150 Cr. Company Equity 16 Cr
means per share worth is nearly 95/-
6) Company having lot of Expansion Plans in WindPower and InfraBusiness.
7) For this year Expected Revenue 75 Cr and Net Profit 2.9 Cr EPS 1.9/-
and 2010-11 NetProfit will zoom with Expansion Income.
Happy Invest ……….. Good Fundamentals and will give good returns from 100% to
300% returns with short and medium terms and Long terms.
Saturday, August 14, 2010
Happy Independence Wishes To All
Tuesday, May 25, 2010
JPASSOCIAT
Disclaimer: www.t14akj.blogspot.com is not a registered Investment Adviser or a Broker/Dealer. The trading of securities may not be suitable for all potential users of the Service. You should be aware of the risks inherent in the stock market. Past performance does not guarantee or imply future success. You cannot assume that profits or gains will be realized. The purchase of securities discussed by the Service may result in the loss of some or all of any investment made. We recommend that you consult a stockbroker or financial advisor before buying or selling securities, or making any investment decisions. You assume the entire cost and risk of any investing and/or trading you choose to undertake.
Monday, May 17, 2010
CYBERMATE INFOTEK LTD At 3/-; TARGET 7/-,10/- and 35/- & other positions
CYBERMATE INFOTEK LTD. (BSE Code: 532271) .
Cybermate Infotek Ltd trading in BSE at 3/- Target of 7/-, 10/- & 35/-
Face Value Rs. 10/-
Book value 17/-
Market Capital 15 Cr; But Company Assets above 50 Cr.
Profit making Company
Company Asstes Commerical Space at Cyber Towers , HITEC City , Hyderabad and Building with land at Secunderabad and Others.
FII's are hevily buying stage. Buy CYBERMATE INFOTEK LTD. at 3/- With target of 10/- to 35/- in Long term as per coming Software projects base and Company Future Plans.
Just Buy and hold 1 month with good appreciation at 100% to 500% Profit because company having good Profit Making and good Book value at 17/- Good projects Proposals and company having Good Assets . All Stocks up 50% to 200% recently; This stock is Pending for up moving in this Small and Mid cap Rally with good Fundamentals and good reserves and Good Profit making company and Good Assets. Lot of Expansion plans is going on.
See last 6 Months Fundamental calls 1) SE Invest given at 185/- Touched 950/- at 10/- face Value (Now Trading at 185/- with 2/- face Value) 2) Bihar Tubes Given at 57/- Touched 127/- 3) IFCI given at 42/- Touched 57/-4) Gujarat Borosil Ltd given at 11/- Touched 17/- 5) VIKAS WSP given at 21/- Touched 35/- 6) Techtran Poly given at 12/- Touched 25/- 7) SURYA PHARMA given at 90/- Touched 187/- 8) SANJIVANI PARENTAL given at 23/- Touched 65/- 9) PONNI SUGARS given at 57/- Touched 175/- 10) RPG LIFE SCINCE given at 23/- touched 78/- 11) EASTERN SILK given at 14/- touched 19/- 12) Comp-U-Learn given at 5/- Touched 35/- (7 times return). 13) Moldtek Plastics given at 32/- Touched 63/- 14) Sathvahana Ispat given at 17/- Touched 53/- 15) Celestial labs guven at 13/- Touched 43/- 16) Navabharath given at 130/- Touched 435/- 17) Compact Disc given at 39/- Touched 94/- 18) Dena Bank given at 35/- touched 85/- 19) Vijaya Bank given at 23/- Touched at 53/- 20) Hotel leela given at 23/- Touched 53/- 21) Hyderabad Industries given at 237/- Toched at 635/- 22) Infotech Enterprices given at 127/- Touched 400/- 23) Natco Pahrma given at 47/- many times Now Toched 175/-
NOTE : Read Disclaimer LAbel Also Before Investing.
Saturday, May 8, 2010
RIL - RNRL Case
My Last call Kunstoffe reached now 12+, Buy JAIPRA for shortterm gain.
Please Read Disclaimer label.
Wednesday, April 28, 2010
RNRL
Don't Buy Dazzel on this level.
Buy also Jaipra, Kunstoffe also.
Sunday, April 18, 2010
Heart Attacks And Drinking Warm Water
.............With warm wishes........
A very good article which takes two minutes to read. I'm sending this to persons I care about.......I hope you do too!!!
This is a very good article. Not only about the warm water after your meal, but about Heart Attacks. The Chinese and Japanese drink hot tea with their meals, not cold water, maybe it is time we adopt their drinking habitwhile eating.
***************************************
A serious note about heart attacks - You should know that not every heart attack symptom is going to be the left arm hurting . Be aware of intense pain in the jaw line.
A cardiologist says if everyone who reads this message sends it to 10 people, you can be sure that we'll save at least one life. Read this & Send to a friend. It could save a life... So, please be a true friend and sendthis article to all your friends you care about.
I JUST DID
Wednesday, April 7, 2010
Short Term
Sunday, March 14, 2010
31 March 2010
Friday, February 26, 2010
Budget & My Recomm.
The INTERNET now has a personality. YOURS! See your Yahoo! Homepage.

